关键词| 非粮生物质进展 | 聚维元创、非粮生物基丁二酸 #聚维元创 已报名参选2026(第四届)DT新叶奖评选 ！ 「DT新叶奖」是专注于生物基领域创新的全球化、综合性奖项，致力于挖掘、展示、表彰生 物基行业的好产品、好企业，被誉为生物基行业的"奥斯卡"。「 2026(第四届)DT新叶奖 」 将于第11届生物基大会暨展览正式揭晓，并举行颁奖典礼。 聚维元创携 生物基丁二胺 、 全生物基包材及底座 、 秸秆源葡萄糖 三大产品，竞选第四届 新叶奖 " 创新材料奖 "、" 创新应用奖 "与" 最具商业价值奖 " 【 生物基能源与材料 】 获 悉，近日， 苏州聚维元创生物科技有限公司 宣布，其非粮生物基丁二酸产品成功通过ISCC PLUS认证，成为 全球首家 专注于非粮生物基丁二酸等生物基产品制造并获得该认证的企业 。 来源：聚维元创 ISCC（国际可持续与碳认证）是全球公认的可持续与碳足迹认证体系，源于欧盟为推行"可再生能源指令"而设立，是绿色供应链的关键准入标准。聚 维元创此次通过认证，意味着其建立了覆盖"原料收集-加工转化-产品输出"的全链条追溯体系，打通了从农业废弃物到高端化学品的高效、透明、可 持续的产业 ...

Core Viewpoint - The overall economic operation in November remained stable, but faced challenges due to external uncertainties and insufficient domestic demand, prompting the need for more proactive macro policies to boost domestic demand and stabilize the economy [1][11]. Economic Data Summary - In November, the industrial added value increased by 4.8% year-on-year, a slight decline of 0.1 percentage points from the previous month. For the first eleven months, the growth was 6.0%, maintaining stability [2]. - The service industry production index grew by 4.2% year-on-year in November, down 0.4 percentage points from the previous month, with a cumulative growth of 5.6% for the first eleven months [2][3]. - The total retail sales of consumer goods increased by 1.3% year-on-year in November, a decline of 1.6 percentage points from the previous month, with a cumulative growth of 4.0% for the first eleven months [5]. - The total import and export value increased by 4.1% year-on-year in November, with exports growing by 5.7% and imports by 1.7%. For the first eleven months, the total value grew by 3.6% [6]. Sector Performance - The manufacturing sector showed stability, with significant growth in specific industries such as biobased materials (29% increase), electronic materials (22.9%), and integrated circuits (24.6%) [2]. - The service sector demonstrated resilience, particularly in modern services, with notable growth in information technology services (12.9%) and leasing services (8.4%) [3]. - Retail sales in cultural and office supplies and communication equipment saw substantial growth, with increases of 11.7% and 20.6% respectively in November [5]. Investment Trends - Fixed asset investment (excluding rural households) decreased by 2.6% year-on-year, with infrastructure investment down by 1.1% and real estate investment down by 15.9%. However, manufacturing investment grew by 1.9% [6][7]. - Equipment and tool purchases increased by 12.2%, indicating ongoing investment in modernization [7]. Policy Implications - The government plans to implement more proactive macroeconomic policies to enhance domestic demand and stabilize the economy, focusing on employment, enterprises, and market expectations [1][11]. - The positive signals in pricing and improvements in corporate profitability suggest a gradual recovery, with industrial profits increasing by 1.9% year-on-year for the first ten months [8][9].

Core Points - On October 29, Zhongxin Co., Ltd. experienced a decline of 1.05% with a trading volume of 25.5154 million yuan [1] - The company had a net financing purchase of 2.1302 million yuan on the same day, with a total financing and securities balance of 214 million yuan, representing 9.54% of its market capitalization [1] - As of September 30, 2025, Zhongxin Co., Ltd. reported a revenue of 1.056 billion yuan, a year-on-year decrease of 8.07%, and a net profit attributable to shareholders of 198 million yuan, down 16.16% year-on-year [1] Financing and Securities - On October 29, Zhongxin Co., Ltd. had a financing purchase of 5.5831 million yuan, with a financing balance of 214 million yuan, which is at a high level compared to the past year [1] - The company had no short selling activity on October 29, with a short selling balance of 0.00 yuan, also indicating a high level compared to the past year [1] Shareholder Information - As of September 30, 2025, the number of shareholders for Zhongxin Co., Ltd. was 3,843, a decrease of 26.60% from the previous period, while the average circulating shares per person increased by 105.34% to 8,018 shares [1] - Since its A-share listing, Zhongxin Co., Ltd. has distributed a total of 98.1492 million yuan in dividends [2] Institutional Holdings - As of September 30, 2025, several funds, including GF Stable Growth Mixed A and GF Ruiyang Three-Year Open Mixed, have exited the top ten circulating shareholders of Zhongxin Co., Ltd. [2]

Core Viewpoint - Recently, Nanling Denning Economic and Trade Co., Ltd. was established with a registered capital of 300,000 RMB, indicating a focus on various manufacturing and sales sectors, particularly in plastic and bio-based materials [1] Company Summary - The legal representative of the newly established company is Chen Sanmei [1] - The registered capital of the company is 300,000 RMB [1] - The company's business scope includes the manufacturing and sales of plastic products, bio-based materials, and various other goods [1] Industry Summary - The company operates in multiple sectors, including the manufacturing and sales of specialized chemical products (excluding hazardous chemicals), packaging equipment, daily wooden products, cork products, food additives, and paper products [1] - The company is also involved in domestic trade agency services, allowing it to operate independently in non-restricted legal projects [1]

Project Overview - The project involves the establishment of a thousand-ton bio-based product production line, focusing on 1,3-PDO, calcium lactate, vanillin, and sialic acid processing [3] - The total investment for the project is 50 million yuan, with 5 million yuan allocated for environmental protection [3] - The production capacity upon completion will be 720 tons of 1,3-PDO, 940 tons of calcium lactate, 30 tons of vanillin, and 10 tons of sialic acid annually [3] Company Background - Si Peng Bio-materials (Nantong) Co., Ltd. is a wholly-owned subsidiary of Shanghai Si Peng Technology Co., Ltd., established in May 2022 [4] - The company focuses on negative carbon synthetic biology and is led by a team of scientists from Shanghai Jiao Tong University [4] - It has developed a unique one-step method for synthesizing polylactic acid (PLA) from carbon dioxide, achieving a 70% reduction in carbon emissions [4] - The company has partnered with Angel Yeast to establish a thousand-ton production line, with products including bio-based polyols and biodegradable plastics [4] Industry Insights - The bio-based materials sector is witnessing significant developments, with various companies making strides in bio-manufacturing technologies [8] - The market for bio-based materials is projected to grow substantially, indicating a competitive landscape for companies involved in this field [8]

Core Viewpoint - The article discusses the announcement of a project by Ningxia Zhongke Biological New Materials Co., Ltd. to produce 110,900 tons of bio-fermentation products annually, highlighting the company's technological upgrades and production capabilities in the bio-manufacturing sector [1]. Project Overview - Project Name: Annual production of 110,900 tons of bio-fermentation products - Construction Unit: Ningxia Zhongke Biological New Materials Co., Ltd. - Nature of Construction: Technological upgrade - Industry Category: C2710 Chemical raw materials and pharmaceutical manufacturing - Investment: 100.89 million yuan - Location: Shizuishan Economic and Technological Development Zone - Land Area: 387,309.18 m², utilizing existing facilities without new land acquisition [2]. Construction Scale - The project includes four flexible production lines: 1. **Long-chain dicarboxylic acid production line**: Annual capacity of 18,000 tons, producing various dicarboxylic acids [3]. 2. **Bio-fermentation functional products production line**: Annual capacity of 5,100 tons, including D-chiro-inositol, coenzyme Q10, and DHA algae oil [4]. 3. **Bio-food production line**: Annual capacity of 63,000 tons, producing calcium propionate and L-malic acid [5]. 4. **Amino acid products production line**: Annual capacity of 24,800 tons, producing various amino acids [6]. Technological Upgrade Scope - The upgrade encompasses fermentation workshops, extraction workshops, refining workshops, drying workshops, liquid bio-fertilizer workshops, tank areas, and power centers [7]. Company Background - Ningxia Zhongke Biological New Materials Co., Ltd. was established on June 2, 2017, with a registered capital of 1.3 billion yuan. The company is involved in the production of feed additives, food additives, fertilizers, and bio-based materials [8]. Financial Performance - The company reported revenue of 345 million yuan and a net loss of 539 million yuan during the reporting period. To address its debt crisis, the company entered pre-restructuring in May 2024, with government support extended until the end of 2024 [9]. - In the first quarter of 2025, the company achieved total revenue of 93.82 million yuan, a year-on-year increase of 74.08%, but still reported a net loss of 64.08 million yuan [11].

Group 1 - The company has completed the registration capital and type changes, along with the filing of the revised Articles of Association, and has obtained a new business license from the Zhejiang Provincial Market Supervision Administration [1][2] - The company is engaged in various activities including the manufacturing and sales of bio-based materials, paper products, and plastic packaging, as well as technical services and equipment manufacturing related to these sectors [1] - The company has undergone significant corporate governance changes, with resolutions passed in board meetings and the annual shareholders' meeting regarding the amendments to the Articles of Association [1]

Core Viewpoint - The article discusses the establishment and growth of Hefei Hydrogen He, a joint venture focused on bio-based materials, highlighting its strategic partnerships and financial performance of its parent company, Kaisa Bio [1][5]. Company Overview - Hefei Hydrogen He was registered on April 9, 2025, in the Hefei area of the China (Anhui) Free Trade Pilot Zone, with a registered capital of 20 million RMB, where Kaisa Bio holds a 55% stake [1]. - The legal representative of Kaisa Bio is Zhang Hongguang, who has been the Vice President since August 2019 [2]. Shareholding Structure - Kaisa Bio holds 55% of Hefei Hydrogen He, contributing 11 million RMB, while 3P.COM Corporation from South Korea holds 45%, contributing 9 million RMB [3]. Strategic Partnerships - In January 2024, Kaisa Bio signed an agreement with 3P.COM to establish a joint venture focusing on thermoplastic bio-based polyamide composite materials for hydrogen storage and transportation, urban air mobility, and wind turbine blades [3]. - Kaisa Bio has also established several other companies, including a joint venture with Ningde Times and Calai Composites, focusing on bio-based composite materials for battery casings and automotive parts [4]. Financial Performance - Kaisa Bio reported a total revenue of 2.958 billion RMB for 2024, marking a year-on-year increase of 39.91%, and a net profit of 489 million RMB, up 33.41% from the previous year [5]. Product Capacity and Sales - Kaisa Bio's total production capacity for various bio-based materials reached nearly 300,000 tons by the end of 2024, with specific capacities as follows: - Bio-based long-chain dicarboxylic acid: 115,000 tons [6] - Bio-based pentamethylenediamine: 50,000 tons [7] - Bio-based polyamide: 100,000 tons [8] - Bio-based continuous fiber thermoplastic composite materials [9]. - The main revenue sources for 2024 were long-chain dicarboxylic acid products, generating 2.670 billion RMB, and bio-based polyamide products, generating 144 million RMB [9]. Application Expansion - In March 2024, Kaisa Bio signed a cooperation agreement with China Merchants Highway and China Merchants Jinling to establish a joint laboratory for bio-based new materials, aiming to enhance performance and reduce costs in highway and green energy materials [11]. - Kaisa Bio provided low-carbon, high-performance composite materials for Qingdao Honghu Aviation Technology's RAP-AT1 active temperature-controlled container, which has entered commercial use [12].